시장보고서

상품코드

1404670

웨어러블 인젝터 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 기술별, 최종 용도별, 용도별, 지역별, 부문별 예측(2024-2030년)

Wearable Injectors Market Size, Share & Trends Analysis Report By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven), By End-use (Hospitals, Clinics), By Application (Oncology), By Region, And Segment Forecasts, 2024 - 2030

발행일: 2023년 11월 | 리서치사:

Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

웨어러블 인젝터 시장 성장 및 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 웨어러블 인젝터 세계 시장 규모는 2024년부터 2030년까지 CAGR 18.11로 확대되어 2030년에는 238억 9,000만 달러에 달할 것으로 예상됩니다.

이 시장은 24시간 모니터링에 대한 수요 증가와 웨어러블 인젝터의 기술 발전으로 인해 예측 기간 동안 유리한 성장을 보일 것으로 예상됩니다.

웨어러블 인젝터의 기술 발전, 예를 들어 블루투스 통합 웨어러블 인젝터는 환자에게 주사 알림 및 치료 체계에 대한 데이터와 같은 알림을 전송합니다. 또한 옵션으로 제공되는 스마트 기능을 통해 의료 네트워크에 연결할 수 있습니다. 이 기기들은 옷에서 접근할 수 있는 버튼이 있고, 오작동을 방지하는 장치도 있습니다. 또한 일부는 가청 및 시각적 상태 표시기와 신호가 있는 제품도 있습니다. 환자는 정맥이나 다른 경로에 비해 최소한의 시간과 노력으로 약물을 피하 자가 투여할 수 있습니다. 환자는 투약을 위해 의료 서비스 제공자를 방문할 필요가 없습니다.

당뇨병, 고혈압 등 생활습관병의 유행은 예측 기간 동안 증가할 것으로 예상됩니다. 이러한 질병은 혈압, 혈당 등 다양한 생리적 매개변수를 24시간 모니터링해야 합니다. 이러한 장치의 고급 생태계는 의료 서비스 제공자가 원격으로 데이터에 액세스하여 임상 판단 시간을 단축할 수 있도록 돕습니다. 이처럼 헬스케어 데이터와 웨어러블 인젝터의 통합은 의사와 의사에게 전달되어 오류를 줄이면서 실시간으로 데이터에 접근할 수 있어 웨어러블 인젝터 시장을 견인할 것으로 예상됩니다.

웨어러블 인젝터 시장 보고서 하이라이트:

온바디 웨어러블 인젝터는 2023년에 가장 큰 매출 점유율을 차지했는데, 이는 약물을 쉽게 방출하고 피부에 부착할 수 있는 접착 패치에 대한 환자 선호도가 높아졌기 때문입니다.
모터 구동 부문은 병원, 클리닉, 소매 체인점, 약국의 수요 증가로 인해 예측 기간 동안 가장 높은 성장률을 기록할 것으로 예상됩니다.
암 분야는 전 세계 암 발병률 증가로 인해 가장 큰 시장 점유율을 차지했습니다.
홈케어 분야는 COVID-19 팬데믹으로 인해 재택치료에 대한 선호도가 높아지면서 홈케어 분야 성장에 긍정적인 영향을 미치고 있어 가장 높은 시장 점유율로 시장을 장악할 것으로 예상됨.
북미 지역은 2023년 33.2%의 가장 큰 매출 점유율을 차지했습니다. 이는 만성 및 생활습관병 유병률의 증가와 의료 인프라의 강화에 기인합니다.

지역별 전망
지역별 웨어러블 인젝터 시장 : 중요한 포인트
북미
- 시장 추정과 예측, 2018-2030년
- 미국
- 캐나다
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 인도
- 중국
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제9장 경쟁 상황

BD
Johnson &Johnson Services, Inc.
F. Hoffmann-La Roche Ltd.
Unilife Corporation
Steady Med Therapeutics, Inc.
Amgen Inc.
Insulet Corporation
Enable Injections
West Pharmaceutical Services, Inc.
CeQur Simplicity

ksm 24.01.18

Wearable Injectors Market Growth & Trends:

The global wearable injectors market size is expected to reach USD 23.89 billion by 2030, expanding at a CAGR of 18.11 from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period owing to technological advancements in wearable injectors coupled with rising demand for round-the-clock monitoring.

Technological advancements in wearable injectors, for instance, Bluetooth integrated wearable injectors, send alerts to patients, such as injection reminders and data regarding their therapy regime. Also, optional smart functionality provides connectivity to the healthcare network. Some of these devices have buttons that are accessible through clothing, and some devices prevent accidental activation. They also have audible and visual status indicators or signals. Patients can self-administer drugs subcutaneously with minimal time and effort as compared to intravenous or other routes. Patients don't need to visit any healthcare provider for the administration.

The prevalence of lifestyle-associated diseases, such as diabetes and hypertension is expected to increase during the forecast period. These diseases demand round-the-clock monitoring of various physiological parameters, such as blood pressure and blood sugar levels. The advanced ecosystem of these devices helps healthcare care providers to access data from remote location, which reduces clinical decision time. Thus, integration of healthcare data with wearable injectors, which gets forwarded to physicians or doctors giving them real-time access to data with reduced errors, is expected to boost the wearable injectors market.

Wearable Injectors Market Report Highlights:

The on-body wearable injectors accounted for the largest revenue share in 2023 owing to the growing preference of the patients for adhesive patches that release the drug conveniently and can be worn on the skin
The motor-driven segment is expected to register the highest growth during the forecast period owing to increasing demand from hospitals, clinics, retail chain stores, and pharmacies
The oncology segment is expected to hold the largest market share due to the globally increasing incidences of cancer
The home care segment is expected to dominate the market with the highest market share owing to increasing inclination towards the home-based treatments onset of COVID-19 pandemic can be seen and it has positively impacted the home care segment growth
North America accounted for the largest revenue share of 33.2% in 2023. It is attributed to the rising prevalence of chronic & lifestyle-related diseases and augmented healthcare infrastructure.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Technology
- 1.1.3. Application
- 1.1.4. End-use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Technology outlook
- 2.2.3. Application outlook
- 2.2.4. End-use outlook
- 2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Wearable Injectors Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
3.4. Wearable Injectors Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
  - 3.4.1.1. Supplier power
  - 3.4.1.2. Buyer power
  - 3.4.1.3. Substitution threat
  - 3.4.1.4. Threat of new entrant
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Technological landscape
  - 3.4.2.3. Economic landscape

Chapter 4. Wearable Injectors Market: Type Estimates & Trend Analysis

4.1. Wearable Injectors Market: Key Takeaways
4.2. Wearable Injectors Market: Movement & Market Share Analysis, 2023 & 2030
4.3. On-body
- 4.3.1. On-body market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Off-body
- 4.4.1. Off-body market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Wearable Injectors Market: Technology Estimates & Trend Analysis

5.1. Wearable Injectors Market: Key Takeaways
5.2. Wearable Injectors Market: Movement & Market Share Analysis, 2023 & 2030
5.3. Spring-based
- 5.3.1. Spring-based market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Motor-driven
- 5.4.1. Motor-driven market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Rotary Pump
- 5.5.1. Rotary pump market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Expanding Battery
- 5.6.1. Expanding battery market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
- 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Wearable Injectors Market: Application Estimates & Trend Analysis

6.1. Wearable Injectors Market: Key Takeaways
6.2. Wearable Injectors Market: Movement & Market Share Analysis, 2023 & 2030
6.3. Oncology
- 6.3.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Infectious Disease
- 6.4.1. Infectious disease market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Cardiovascular Disease
- 6.5.1. Cardiovascular disease market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Autoimmune Disease
- 6.6.1. Autoimmune disease market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Immunodeficiency
- 6.7.1. Immunodeficiency market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Others
- 6.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Wearable Injectors Market: End-use Estimates & Trend Analysis

7.1. Wearable Injectors Market: Key Takeaways
7.2. Wearable Injectors Market: Movement & Market Share Analysis, 2023 & 2030
7.3. Hospitals
- 7.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Clinics
- 7.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Home Care
- 7.5.1. Home care market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Others
- 7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Wearable Injectors Market: Regional Estimates & Trend Analysis

8.1. Regional Outlook
8.2. Wearable Injectors Market by Region: Key Takeaways
8.3. North America
- 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.3.2. U.S.
  - 8.3.2.1. Key country dynamics
  - 8.3.2.2. Competitive Scenario
  - 8.3.2.3. Regulatory framework
  - 8.3.2.4. Reimbursement scenario
  - 8.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
- 8.3.3. Canada
  - 8.3.3.1. Key country dynamics
  - 8.3.3.2. Competitive Scenario
  - 8.3.3.3. Regulatory framework
  - 8.3.3.4. Reimbursement scenario
  - 8.3.3.5. Canada market estimates and forecasts, 2018 - 2030
8.4. Europe
- 8.4.1. UK
  - 8.4.1.1. Key country dynamics
  - 8.4.1.2. Competitive Scenario
  - 8.4.1.3. Regulatory framework
  - 8.4.1.4. Reimbursement scenario
  - 8.4.1.5. UK market estimates and forecasts, 2018 - 2030
- 8.4.2. Germany
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Competitive Scenario
  - 8.4.2.3. Regulatory framework
  - 8.4.2.4. Reimbursement scenario
  - 8.4.2.5. Germany market estimates and forecasts, 2018 - 2030
- 8.4.3. France
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Competitive Scenario
  - 8.4.3.3. Regulatory framework
  - 8.4.3.4. Reimbursement scenario
  - 8.4.3.5. France market estimates and forecasts, 2018 - 2030
- 8.4.4. Italy
  - 8.4.4.1. Key country dynamics
  - 8.4.4.2. Competitive Scenario
  - 8.4.4.3. Regulatory framework
  - 8.4.4.4. Reimbursement scenario
  - 8.4.4.5. Italy market estimates and forecasts, 2018 - 2030
- 8.4.5. Spain
  - 8.4.5.1. Key country dynamics
  - 8.4.5.2. Competitive Scenario
  - 8.4.5.3. Regulatory framework
  - 8.4.5.4. Reimbursement scenario
  - 8.4.5.5. Spain market estimates and forecasts, 2018 - 2030
- 8.4.6. Denmark
  - 8.4.6.1. Key country dynamics
  - 8.4.6.2. Competitive Scenario
  - 8.4.6.3. Regulatory framework
  - 8.4.6.4. Reimbursement scenario
  - 8.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
- 8.4.7. Sweden
  - 8.4.7.1. Key country dynamics
  - 8.4.7.2. Competitive Scenario
  - 8.4.7.3. Regulatory framework
  - 8.4.7.4. Reimbursement scenario
  - 8.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
- 8.4.8. Norway
  - 8.4.8.1. Key country dynamics
  - 8.4.8.2. Competitive Scenario
  - 8.4.8.3. Regulatory framework
  - 8.4.8.4. Reimbursement scenario
  - 8.4.8.5. Norway market estimates and forecasts, 2018 - 2030
8.5. Asia Pacific
- 8.5.1. Japan
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Competitive Scenario
  - 8.5.1.3. Regulatory framework
  - 8.5.1.4. Reimbursement scenario
  - 8.5.1.5. Japan market estimates and forecasts, 2018 - 2030
- 8.5.2. India
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Competitive Scenario
  - 8.5.2.3. Regulatory framework
  - 8.5.2.4. Reimbursement scenario
  - 8.5.2.5. India market estimates and forecasts, 2018 - 2030
- 8.5.3. China
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Competitive Scenario
  - 8.5.3.3. Regulatory framework
  - 8.5.3.4. Reimbursement scenario
  - 8.5.3.5. China market estimates and forecasts, 2018 - 2030
- 8.5.4. South Korea
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Competitive Scenario
  - 8.5.4.3. Regulatory framework
  - 8.5.4.4. Reimbursement scenario
  - 8.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
- 8.5.5. Australia
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Competitive Scenario
  - 8.5.5.3. Regulatory framework
  - 8.5.5.4. Reimbursement scenario
  - 8.5.5.5. Australia market estimates and forecasts, 2018 - 2030
- 8.5.6. Thailand
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Competitive Scenario
  - 8.5.6.3. Regulatory framework
  - 8.5.6.4. Reimbursement scenario
  - 8.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
8.6. Latin America
- 8.6.1. Brazil
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Competitive Scenario
  - 8.6.1.3. Regulatory framework
  - 8.6.1.4. Reimbursement scenario
  - 8.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
- 8.6.2. Mexico
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Competitive Scenario
  - 8.6.2.3. Regulatory framework
  - 8.6.2.4. Reimbursement scenario
  - 8.6.2.5. Mexico market estimates and forecasts, 2018 - 2030
- 8.6.3. Argentina
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Competitive Scenario
  - 8.6.3.3. Regulatory framework
  - 8.6.3.4. Reimbursement scenario
  - 8.6.3.5. Argentina market estimates and forecasts, 2018 - 2030
8.7. MEA
- 8.7.1. South Africa
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Competitive Scenario
  - 8.7.1.3. Regulatory framework
  - 8.7.1.4. Reimbursement scenario
  - 8.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
- 8.7.2. Saudi Arabia
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Competitive Scenario
  - 8.7.2.3. Regulatory framework
  - 8.7.2.4. Reimbursement scenario
  - 8.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 8.7.3. UAE
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Competitive Scenario
  - 8.7.3.3. Regulatory framework
  - 8.7.3.4. Reimbursement scenario
  - 8.7.3.5. UAE market estimates and forecasts, 2018 - 2030
- 8.7.4. Kuwait
  - 8.7.4.1. Key country dynamics
  - 8.7.4.2. Competitive Scenario
  - 8.7.4.3. Regulatory framework
  - 8.7.4.4. Reimbursement scenario
  - 8.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

9.1. BD
9.2. Johnson & Johnson Services, Inc.
9.3. F. Hoffmann-La Roche Ltd.
9.4. Unilife Corporation
9.5. Steady Med Therapeutics, Inc.
9.6. Amgen Inc.
9.7. Insulet Corporation
9.8. Enable Injections
9.9. West Pharmaceutical Services, Inc.
9.10. CeQur Simplicity

웨어러블 인젝터 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 기술별, 최종 용도별, 용도별, 지역별, 부문별 예측(2024-2030년)

Wearable Injectors Market Size, Share & Trends Analysis Report By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven), By End-use (Hospitals, Clinics), By Application (Oncology), By Region, And Segment Forecasts, 2024 - 2030

웨어러블 인젝터 시장 성장 및 동향:

웨어러블 인젝터 시장 보고서 하이라이트:

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 웨어러블 인젝터 시장 변수, 동향, 범위

제4장 웨어러블 인젝터 시장 : 유형 추정·동향 분석

제5장 웨어러블 인젝터 시장 : 기술 추정·동향 분석

제6장 웨어러블 인젝터 시장 : 용도 추정·동향 분석

제7장 웨어러블 인젝터 시장 : 최종 용도 추정·동향 분석

제8장 웨어러블 인젝터 시장 : 지역 추정·동향 분석